Nichols, R., Doty, E., Sacco, S., Ruff, D., Pearlman, E., & Aurora, S. K. (2018). Analysis of Initial Nonresponders to Galcanezumab in Patients With Episodic or Chronic Migraine: Results From the EVOLVE‐1, EVOLVE‐2, and REGAIN Randomized, Double‐Blind, Placebo‐Controlled Studies. Headache.
Chicago-стиль цитированияNichols, Russell, Erin Doty, Sara Sacco, Dustin Ruff, Eric Pearlman, and Sheena K. Aurora. "Analysis of Initial Nonresponders to Galcanezumab in Patients With Episodic or Chronic Migraine: Results From the EVOLVE‐1, EVOLVE‐2, and REGAIN Randomized, Double‐Blind, Placebo‐Controlled Studies." Headache 2018.
MLA-цитированиеNichols, Russell, et al. "Analysis of Initial Nonresponders to Galcanezumab in Patients With Episodic or Chronic Migraine: Results From the EVOLVE‐1, EVOLVE‐2, and REGAIN Randomized, Double‐Blind, Placebo‐Controlled Studies." Headache 2018.